Medicinova Stock Analysis

MediciNova Stock Analysis Notes

About 21.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.83. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MediciNova recorded a loss per share of 0.21. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 31st of October 2006. MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California. Medicinova operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. To find out more about MediciNova contact the company at 858 373 1500 or learn more at https://www.medicinova.com.

MediciNova Investment Alerts

MediciNova Upcoming and Recent Events

MediciNova Largest EPS Surprises

View All Earnings Estimates

MediciNova Environmental, Social, and Governance (ESG) Scores

MediciNova Thematic Classifications

MediciNova Stock Institutional Investors

Note, although MediciNova's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

MediciNova Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 100.54 M.

MediciNova Profitablity

Management Efficiency

MediciNova has return on total asset (ROA) of (0.0951) % which means that it has lost $0.0951 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1332) %, meaning that it created substantial loss on money invested by shareholders. MediciNova's management efficiency ratios could be used to measure how well MediciNova manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.16 in 2025. Return On Capital Employed is likely to drop to -0.15 in 2025. At this time, MediciNova's Intangible Assets are fairly stable compared to the past year. Intangibles To Total Assets is likely to climb to 0.34 in 2025, whereas Total Assets are likely to drop slightly above 62.3 M in 2025.

Technical Drivers

As of the 31st of January, MediciNova secures the Risk Adjusted Performance of 0.0633, mean deviation of 3.53, and Downside Deviation of 3.99. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MediciNova, as well as the relationship between them. Please verify MediciNova mean deviation, information ratio, as well as the relationship between the Information Ratio and downside variance to decide if MediciNova is priced some-what accurately, providing market reflects its recent price of 2.05 per share. Please also check out MediciNova total risk alpha, which is currently at (0.32) to check the company can sustain itself at a future point.

MediciNova Price Movement Analysis

MediciNova Insider Trading Activities

MediciNova Outstanding Bonds

MediciNova Predictive Daily Indicators

MediciNova Corporate Filings

MediciNova Forecast Models

MediciNova's time-series forecasting models are one of many MediciNova's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MediciNova's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how MediciNova prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MediciNova shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MediciNova. By using and applying MediciNova Stock analysis, traders can create a robust methodology for identifying MediciNova entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MediciNova analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MediciNova analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

MediciNova stock analysis indicators help investors evaluate how MediciNova stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MediciNova shares will generate the highest return on investment. By understating and applying MediciNova stock analysis, traders can identify MediciNova position entry and exit signals to maximize returns.

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.